Cargando…
Multidisciplinary Perspectives of Current Approaches and Clinical Gaps in the Management of Hyperphosphatemia
Population-based studies have shown that most patients with advanced chronic kidney disease (CKD) do not have optimal phosphate levels. Meta-analyses suggest that there is a morbidity and mortality benefit associated with the lowering of serum phosphate levels. However, to date there is no conclusiv...
Autores principales: | Vallée, Michel, Weinstein, Jordan, Battistella, Marisa, Papineau, Roxanne, Moseley, Dianne, Wong, Gordon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354740/ https://www.ncbi.nlm.nih.gov/pubmed/34393498 http://dx.doi.org/10.2147/IJNRD.S318593 |
Ejemplares similares
-
Optimal management of hyperphosphatemia in end-stage renal disease: an Indian perspective
por: Reddy, Yogesh NV, et al.
Publicado: (2014) -
Hyperphosphatemia and Cardiovascular Disease
por: Zhou, Chao, et al.
Publicado: (2021) -
Use of Nicotinamide to Treat Hyperphosphatemia in Dialysis Patients
por: Lenglet, Aurélie, et al.
Publicado: (2013) -
Hyperphosphatemia Management in Patients with Chronic Kidney Disease
por: Shaman, Ahmed M., et al.
Publicado: (2016) -
Hyperphosphatemia in patients with ESRD: assessing the current evidence linking outcomes with treatment adherence
por: Covic, Adrian, et al.
Publicado: (2013)